MiR-100 overexpression attenuates high fat diet induced weight gain, liver steatosis, hypertriglyceridemia and development of metabolic syndrome in mice
Abstract Background Diet-induced obesity can result in the development of a diverse spectrum of cardiovascular and metabolic diseases, including type 2 diabetes, dyslipidemia, non-alcoholic liver steatosis and atherosclerotic disease. MicroRNAs have been described to be important regulators of metab...
Main Authors: | Christian Smolka, Delia Schlösser, Catherine Hohnloser, Xavier Bemtgen, Caterina Jänich, Laura Schneider, Julien Martin, Dietmar Pfeifer, Martin Moser, Peter Hasselblatt, Christoph Bode, Sebastian Grundmann, Franziska Pankratz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10020-021-00364-6 |
Similar Items
-
Deletions of Fstl3 and/or Fst Isoforms 303 and 315 Results in Hepatic Steatosis
by: Ungerleider, Nathan A
Published: (2010) -
Treatment of growth hormone attenuates hepatic steatosis in hyperlipidemic mice via downregulation of hepatic CD36 expression
by: Hyung Seok Jang, et al.
Published: (2020-05-01) -
CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis[S]
by: Robin D. Clugston, et al.
Published: (2014-02-01) -
Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans
by: Jinyun Bai, et al.
Published: (2020-07-01) -
Metabolic Pancreatitis: Pancreatic Steatosis, Hypertriglyceridemia, and Associated Chronic Pancreatitis in 3 Patients with Metabolic Syndrome
by: Constantine Melitas, et al.
Published: (2018-06-01)